levofloxacin has been researched along with gsk1322322 in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (gsk1322322) | Trials (gsk1322322) | Recent Studies (post-2010) (gsk1322322) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 16 | 8 | 16 |
| Protein | Taxonomy | levofloxacin (IC50) | gsk1322322 (IC50) |
|---|---|---|---|
| Peptide deformylase | Staphylococcus aureus | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Hu, W; Lv, F; Tang, Y; Wei, J; Zhu, T | 1 |
| Aubart, K; Butler, D; Dubois, J; Dubois, M; Martel, JF | 1 |
2 other study(ies) available for levofloxacin and gsk1322322
| Article | Year |
|---|---|
New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment.
Topics: Amidohydrolases; Animals; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2016 |
In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Bridged Bicyclo Compounds, Heterocyclic; Humans; Hydroxamic Acids; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests | 2015 |